BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35034646)

  • 21. How bariatric surgery affects liver volume and fat density in NAFLD patients.
    Luo RB; Suzuki T; Hooker JC; Covarrubias Y; Schlein A; Liu S; Schwimmer JB; Reeder SB; Funk LM; Greenberg JA; Campos GM; Sandler BJ; Horgan S; Sirlin CB; Jacobsen GR
    Surg Endosc; 2018 Apr; 32(4):1675-1682. PubMed ID: 29218660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Abdalla MA; Akhlaghi S; Sathyapalan T; Sahebkar A
    Eat Weight Disord; 2022 Mar; 27(2):693-700. PubMed ID: 33999371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery.
    Somda S; Lebrun A; Tranchart H; Lamouri K; Prevot S; Njike-Nakseu M; Gaillard M; Lainas P; Balian A; Dagher I; Perlemuter G; Naveau S; Voican CS
    PLoS One; 2019; 14(5):e0217093. PubMed ID: 31125357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease.
    Batman B; Altun H; Simsek B; Aslan E; Namli Koc S
    Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):509-512. PubMed ID: 31107849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
    Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation Between Sex Hormones and Non-alcoholic Fatty Liver Disease Before and After Laparoscopic Sleeve Gastrectomy.
    Dilimulati D; Cai M; Lin Z; Zhang Y; Du L; Zhou D; Zhu J; Su L; Wang Y; Zhang M; Qu S
    Obes Surg; 2021 Nov; 31(11):4901-4910. PubMed ID: 34453689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
    Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative circulating peroxiredoxin 1 levels as a predictor of non-alcoholic fatty liver disease remission after laparoscopic bariatric surgery.
    Cheng X; Fu Z; Xie W; Zhu L; Meng J
    Front Endocrinol (Lausanne); 2022; 13():1072513. PubMed ID: 36619535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
    Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
    Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
    Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
    Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of Liver Steatosis Quantified by MR Imaging and MR Spectroscopy, in Morbidly Obese Patients Undergoing Sleeve Gastrectomy: Short-Term Outcomes.
    Alsina ME; Ruiz-Tovar J; Bernabeu A
    Obes Surg; 2017 Jul; 27(7):1724-1728. PubMed ID: 27885531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy.
    Algooneh A; Almazeedi S; Al-Sabah S; Ahmed M; Othman F
    Surg Endosc; 2016 May; 30(5):1983-7. PubMed ID: 26194256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.
    Perdomo CM; Gómez-Ambrosi J; Becerril S; Valentí V; Moncada R; Fernández-Sáez EM; Méndez-Giménez L; Ezquerro S; Catalán V; Silva C; Escalada J; Frühbeck G; Rodríguez A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients.
    Ayloo S; Guss C; Pentakota SR; Hanna J; Molinari M
    Transplant Proc; 2020; 52(1):276-283. PubMed ID: 31889539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nonalcoholic fatty liver disease: clinical and histological characteristics in obese who underwent bariatric surgery].
    Bitencourt AG; Cotrim HP; Alves E; Almeida AM; Barbosa DB; Santos AS; Lobo AP; Athayde LG; Rios A; Gouveia M; Freitas LA
    Acta Gastroenterol Latinoam; 2007 Dec; 37(4):224-30. PubMed ID: 18254260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.